Main, Ailsa Maria
Sørensen, Louise Holst
Winge, Sofia Boeg
Fode, Mikkel
Sønksen, Jens
Juul, Anders
Østergren, Peter Busch
Mørup, Nina
Almstrup, Kristian
Funding for this research was provided by:
Svend Andersen Fonden
Novo Nordisk Fonden (NNF210C0069913)
Novo Nordisk Fonden (NNF21C0069969)
Novo Nordisk Fonden (NNF210C0069913)
Sundhed og Sygdom, Det Frie Forskningsråd (1030-0381B)
Sundhed og Sygdom, Det Frie Forskningsråd (1030-0381B)
Article History
Received: 2 September 2025
Accepted: 29 January 2026
First Online: 3 February 2026
Declarations
:
: MF has been speaker and advisory board member of Astellas Pharma. All other authors have nothing to disclose.